It has previously been demonstrated that a SNP in the promoter CpG island of MLH1 (MLH1-93G>A, rs1800734) is associated with MLH1 CpG island hypermethylation, loss of protein expression, MSI, and overall increased risk of MSI-H CRC [21, 22]. Here, MLH1 is linked to colorectal carcinoma.